VPN Plus+ Exclusive
Treating canine osteoarthritis without opioids
March 4, 2021There is no reason to mask dogs’ arthritis pain with drugs. There are several techniques available to veterinarians that not only safely and effectively treat osteoarthritis pain, they can address its root cause: inflamed and damaged joints.
Laser therapy—Indications and contraindications
March 27, 2019Photobiomodulation—a.k.a laser therapy—has become commonplace in veterinary medicine, with knowledge gained over the last eight to 10 years coming from evidence-based data and shared clinical experience. Achieving predictable and reproducible results with laser therapy is dependent on properly managed treatments, proper dosing, effective use of therapy laser hardware and software, and appropriate treatment technique.1 Low-level laser therapy (LLLT) applies low-level (low-power) lasers to the surface of or in orifices of the body. Whereas high-power lasers …
Second annual ALSC symposium to take place in Phoenix, Ariz.
March 14, 2019Veterinarians looking to learn more about surgical CO2 lasers can get their fill at the American Laser Study Club (ALSC) symposium. Held in Phoenix, Ariz., from March 29 to 31, the event will feature the following laser-surgery techniques and photobiomodulation topics: • “A comparison between carbon dioxide surgical laser and non-laser excision of cutaneous and subcutaneous soft tissue sarcomas and mast cell tumors in dogs”—Lori Agulian, DVM; • “Comparison of the hemodynamic response in …
Companion Animal Health targets mast cell tumors with nanomedicine
October 4, 2018Companion Animal Health (CAH) in Newark, Del., has secured an exclusive partnership with Nanospectra Biosciences Inc., a medical device company focused on the use of nanomedicine in selective thermal ablation of solid tumors. In 2017, CAH initiated clinical trials in the treatment of canine mast cell tumors using a combined laser and nanoshell therapy procedure that has the ability to destroy solid tumors without damaging adjacent healthy tissue. “Initial results are very encouraging and we …